Literature DB >> 13486940

Unusual toxic manifestations to amodiaquin (camoquin).

D C BLEIL.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/injurious effects

Mesh：

Substances：

Year:  1958        PMID： 13486940     DOI： 10.1001/archderm.1958.01560010108016

Source DB:  PubMed          Journal:  AMA Arch Derm        ISSN： 0096-5359


× No keyword cloud information.
  6 in total

1.  Chloroquine diphosphate in rheumatoid arthritis. A controlled trial.

Authors:  A J POPERT; K A MEIJERS; J SHARP; F BIER
Journal:  Ann Rheum Dis       Date:  1961-03       Impact factor: 19.103

2.  Synthetic antimalarial drug therapy in lupus erythematosus and polymorphous light eruptions.

Authors:  J H EPSTEIN
Journal:  Calif Med       Date:  1960-02

3.  [On visual disturbances and eye changes in quinoline therapy of primary chronic articular rheumatism].

Authors:  R MARX; P BRECH; T MEISNER
Journal:  Klin Wochenschr       Date:  1960-05-01

4.  OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE.

Authors:  H E Hobbs; S P Eadie; F Somerville
Journal:  Br J Ophthalmol       Date:  1961-04       Impact factor: 4.638

5.  Drug-induced lipidoses of the cornea and conjunctiva.

Authors:  D J D'Amico; K R Kenyon
Journal:  Int Ophthalmol       Date:  1981-08       Impact factor: 2.031

6.  In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax.

Authors:  Mikhail Martchenko Shilman; Gloria Bartolo; Saleem Alameh; Johnny W Peterson; William S Lawrence; Jennifer E Peel; Satheesh K Sivasubramani; David W C Beasley; Christopher K Cote; Samandra T Demons; Stephanie A Halasahoris; Lynda L Miller; Christopher P Klimko; Jennifer L Shoe; David P Fetterer; Ryan McComb; Chi-Lee C Ho; Kenneth A Bradley; Stella Hartmann; Luisa W Cheng; Marina Chugunova; Chiu-Yen Kao; Jennifer K Tran; Aram Derbedrossian; Leeor Zilbermintz; Emiene Amali-Adekwu; Anastasia Levitin; Joel West
Journal:  ACS Infect Dis       Date:  2021-07-04       Impact factor: 5.084
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.